Hem › Blodcancer › Nebraska › Omaha
Kliniska studier för Blodcancer i Omaha, NE
10 studier för Blodcancer söker deltagare vid platser i och runt Omaha (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekryterarObservationsstudieFriska volontärer välkomna
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
RekryterarObservationsstudie
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9 mi bort
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
RekryterarFas 1
- The University of Nebraska Medical Center, Omaha
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RekryterarFas 1
- University of Nebraska Medical Center, Omaha
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
RekryterarFas 1
- University of Nebraska Medical Center, Omaha
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekryterarObservationsstudie
- University of Nebraska Medical Center, Omaha
Halt Aging in Survivors of Blood Cancers
Rekryterar
- University of Nebraska Medical Center, Omaha
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
RekryterarFas 1/2
- Nebraska Cancer Specialists, Omaha
- University of Nebraska Medical Center, Omaha
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RekryterarFas 1/2
- Fred and Pamela Buffett Cancer Center, Omaha
Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
RekryterarFas 2
- University of Nebraska Medical Center, Omaha
Blodcancer-studier i andra städer
- Houston, TX46 studier
- New York City, NY26 studier
- Boston, MA25 studier
- Washington, DC19 studier
- Baltimore, MD18 studier
- Seattle, WA18 studier
- Los Angeles, CA17 studier
- Durham, NC16 studier
- Chicago, IL15 studier
- Philadelphia, PA14 studier
- Atlanta, GA13 studier
- Nashville, TN13 studier
Andra studier i Omaha
- Prostatacancer27 studier
- Icke-småcellig lungcancer24 studier
- Bröstcancer22 studier
- Kolorektal cancer18 studier
- Cancer (alla typer)18 studier
- Multipelt myelom16 studier
- Non-Hodgkins lymfom14 studier
- Äggstockscancer14 studier
- Bukspottkörtelcancer14 studier
- Plattenepitelcancer i huvud och hals13 studier
- Hjärtsvikt13 studier
- Metastaserande cancer13 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.